All In Biotech

Free tool

FAERS Monitor: Pataday Once Daily Relief

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021545 or its brand name (Pataday Once Daily Relief, Olopatadine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,332

Serious

1,430

27% of reports

Hospitalization

807

Death reported

196

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure1,934
  • drug ineffective543
  • eye irritation282
  • vision blurred223
  • eye discharge175
  • eye pain164
  • headache161
  • ocular hyperaemia136
  • eye pruritus135
  • nausea129
  • diarrhoea121
  • fatigue114
  • pruritus109
  • condition aggravated108
  • hypersensitivity107

Reports by year received

View as table
YearReports
20046
200510
20065
20078
200817
200918
201026
201125
201224
201330
201429
201549
201682
201791
2018131
2019191
20201,941
2021380
2022408
2023425
2024431
2025513
2026492

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,827 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment failureSignal1,93494.390.9174,893
eye dischargeSignal17567.658.311,222
eye irritationSignal28219.417.34,897
eye pruritusSignal13515.913.51,867
eye painSignal16411.59.91,561
ocular hyperaemiaSignal13611.39.61,270
vision blurredSignal2236.45.61,019
hypersensitivitySignal1072.31.976
drug ineffective5431.61.5139
condition aggravated1081.41.212
pruritus1091.10.91
headache1611.00.90
diarrhoea1210.70.611
nausea1290.60.526
fatigue1140.60.536

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.